Who owns TERNS PHARMACEUTICALS INC?
- Ticker: TERN
- CUSIP Number: 880881107
Tip: Access positions for across all investors
Analyze quarterly positions in Terns Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Terns Pharmaceuticals stock
Who bought or sold TERNS PHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| OrbiMed Advisors | 7.6M | $49M | 0% | Dec 2023 |
|
| Vivo Capital | 6.7M | $44M | 0% | Mar 2024 |
|
| VR Adviser | 4.5M | $29M | 45% | Dec 2023 |
|
| Braidwell | 2.3M | $15M | -18% | Dec 2023 |
|
| Franklin Resources | 2.3M | $15M | 7% | Dec 2023 |
|
| Vanguard Group | 2.2M | $14M | -1% | Dec 2023 |
|
| Fairmount Funds Management | 2.0M | $13M | 0% | Dec 2023 |
|
| Millennium Management | 2.0M | $13M | 26% | Dec 2023 |
|
| Henderson Group | 1.4M | $9.2M | 100% | Dec 2023 |
|
| Dr. Jeffrey R. Jay, M.D. | 1.3M | $8.5M | 103% | Dec 2023 |
|
| Perceptive Advisors | 1.1M | $7.0M | 0% | Dec 2023 |
|
| Decheng Capital | 714k | $4.6M | 100% | Dec 2023 |
|
| Norges Bank Investment Management | 427k | $2.8M | 100% | Dec 2023 |
|
| Schonfeld Strategic Advisors | 408k | $2.6M | 346% | Dec 2023 |
|
| Russell Investments | 278k | $1.8M | 100% | Dec 2023 |
|
| Jpmorgan Chase & Co | 218k | $1.4M | -23% | Dec 2023 |
|
| Samsara BioCapital | 202k | $1.3M | 0% | Dec 2023 |
|
| Ikarian Capital | 166k | $1.1M | -1% | Dec 2023 |
|
| Bank of New York Mellon | 120k | $779k | -7% | Dec 2023 |
|
| Charles Schwab Investment Management | 115k | $744k | 0% | Dec 2023 |
|
| UBS Group | 109k | $704k | 404% | Dec 2023 |
|
| Goldman Sachs Group | 86k | $556k | -67% | Dec 2023 |
|
| Barclays | 85k | $548k | 56% | Dec 2023 |
|
| Dimensional Fund Advisors | 78k | $505k | -12% | Dec 2023 |
|
| Swiss National Bank | 68k | $441k | 0% | Dec 2023 |
|
| Citadel Advisors | 65k | $420k | -41% | Dec 2023 |
|
| Jane Street | 65k | $418k | 100% | Dec 2023 |
|
| Bank of America Corporation | 59k | $382k | 111% | Dec 2023 |
|
| Rhumbline Advisers | 58k | $374k | -3% | Dec 2023 |
|
| Mirae Asset Global Investments | 41k | $264k | 0% | Dec 2023 |
|
| Credit Suisse | 34k | $220k | 6% | Dec 2023 |
|
| Legal & General Group | 28k | $179k | 0% | Dec 2023 |
|
| Alliancebernstein | 26k | $168k | 0% | Dec 2023 |
|
| Walleye Trading Advisors | 25k | $164k | -81% | Dec 2023 |
|
| MetLife Investment Advisors | 23k | $150k | 0% | Dec 2023 |
|
| Deutsche Bank Aktiengesellschaft | 23k | $149k | 2% | Dec 2023 |
|
| American International | 21k | $138k | 0% | Dec 2023 |
|
| T. Rowe Price Associates | 18k | $120k | 4% | Dec 2023 |
|
| Ubs Global Asset Management Americas | 18k | $116k | 100% | Dec 2023 |
|
| New York State Common Retirement Fund | 18k | $114k | 0% | Dec 2023 |
|
| Deerfield Management Company | 17k | $112k | 100% | Dec 2023 |
|
| Dynamic Technology Lab Private | 16k | $106k | 100% | Dec 2023 |
|
| Martingale Asset Management | 16k | $100k | 100% | Dec 2023 |
|
| Royal Bank of Canada | 14k | $92k | -65% | Dec 2023 |
|
| Virtus ETF Advisers | 14k | $93k | 70% | Dec 2023 |
|
| Balyasny Asset Management | 14k | $90k | 100% | Dec 2023 |
|
| ADAR1 Capital Management | 13k | $84k | 100% | Dec 2023 |
|
| Florida State Board of Administration | 12k | $81k | 0% | Dec 2023 |
|
| Wells Fargo & Company | 12k | $78k | 27% | Dec 2023 |
|
| Brevan Howard Capital Management | 11k | $70k | 100% | Dec 2023 |
|
| Bleakley Financial Group | 11k | $68k | 100% | Dec 2023 |
|
| Sawtooth Asset Management | 11k | $68k | 100% | Dec 2023 |
|
| Zurcher Kantonalbank | 9.4k | $61k | -16% | Dec 2023 |
|
| AJOVista | 8.9k | $58k | 100% | Dec 2023 |
|
| China Universal Asset Management | 7.1k | $46k | 358% | Dec 2023 |
|
| Citigroup | 7.1k | $43k | 748% | Dec 2023 |
|
| Summit Investment Advisors | 3.5k | $23k | 0% | Dec 2023 |
|
| Metropolitan Life Insurance Company | 2.4k | $16k | 0% | Dec 2023 |
|
| Amalgamated Bank | 1.4k | $9.0k | -73% | Mar 2024 |
|
| GAMMA Investing | 1.0k | $6.7k | 613% | Mar 2024 |
|
| Signature | 853.00 | $5.5k | 28% | Dec 2023 |
|
| Us Bancorp | 386.00 | $2.5k | 30% | Dec 2023 |
|
| Quadrant Capital | 339.00 | $2.2k | 100% | Dec 2023 |
|
| Zrc Wealth Management | 225.00 | $1.5k | 100% | Mar 2024 |
|
| Capital Advisors | 183.00 | $1.0k | 0% | Mar 2024 |
|
| Simplex Trading | 170.00 | $1.0k | 100% | Dec 2023 |
|
| Daiwa Securities Group | 151.00 | $999.997500 | 0% | Dec 2023 |
|
| Parallel Advisors | 114.00 | $739.996800 | 100% | Dec 2023 |
|
| ICA Group Wealth Management | 80.00 | $519.000000 | 100% | Dec 2023 |
|
| NISA Investment Advisors | 23.00 | $149.000900 | 0% | Dec 2023 |
|
| Farther Finance Advisors | 20.00 | $130.000000 | 100% | Dec 2023 |
|
| Pnc Financial Services | 8.00 | $52.000000 | 100% | Dec 2023 |
|
Who sold out of Terns Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Point72 Asset Management | Sep 2023 | 571k | $2.9M |
| Cubist Systematic Strategies | Sep 2023 | 135k | $679k |
| Polar Securities | Sep 2023 | 100k | $503k |
| Graham Capital Management | Sep 2023 | 83k | $417k |
| Connor, Clark & Lunn Investment Management | Sep 2023 | 68k | $342k |
| ALPS Advisors | Sep 2023 | 45k | $227k |
| Trexquant Investment | Sep 2023 | 32k | $159k |
| AQR Capital Management | Sep 2023 | 17k | $86k |
| Point72 Middle East FZE | Sep 2023 | 14k | $70k |
| Fortitude Family Office | Dec 2023 | 300.00 | $1.9k |